DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
56	ベーチェット病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01306955 (ClinicalTrials.gov)	February 2010	1/3/2011	The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease	The Efficacy of Intravenous Pulses of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease, a Double Blind Pilot Study	Behcet's Disease	Drug: methylorednisolone;Other: dextrose water 5%	Tehran University of Medical Sciences	NULL	Recruiting	10 Years	70 Years	Both	34	Phase 4	Iran, Islamic Republic of

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01306955
(ClinicalTrials.gov)

February 2010

1/3/2011

The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease

The Efficacy of Intravenous Pulses of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease, a Double Blind Pilot Study

Behcet's Disease

Drug: methylorednisolone;Other: dextrose water 5%

Tehran University of Medical Sciences

NULL

Recruiting

10 Years

70 Years

Both

Phase 4

Iran, Islamic Republic of